ABSTRACT Background: Three daily portions of whole-grain foods could lower cardiovascular disease risk, but a comprehensive intervention trial was needed to confirm this recommendation. Objectives: We aimed to assess the effects of consumption of 3 daily portions of whole-grain foods (provided as only wheat or a mixture of wheat and oats) on markers of cardiovascular disease risk in relatively high-risk individuals. Design: This was a randomized controlled dietary trial in middleaged healthy individuals. After a 4-wk run-in period with a refined diet, we randomly allocated volunteers to a control (refined diet), wheat, or wheat + oats group for 12 wk. The primary outcome was a reduction of cardiovascular disease risk factors by dietary intervention with whole grains, which included lipid and inflammatory marker concentrations, insulin sensitivity, and blood pressure. Results: We recruited a total of 233 volunteers; 24 volunteers withdrew, and 3 volunteers were excluded. Systolic blood pressure and pulse pressure were significantly reduced by 6 and 3 mm Hg, respectively, in the whole-grain foods groups compared with the control group. Systemic markers of cardiovascular disease risk remained unchanged apart from cholesterol concentrations, which decreased slightly but significantly in the refined group. Conclusions: Daily consumption of 3 portions of whole-grain foods can significantly reduce cardiovascular disease risk in middle-aged people mainly through blood pressure-lowering mechanisms. The observed decrease in systolic blood pressure could decrease the incidence of coronary artery disease and stroke by !15% and 25%, respectively. This trial was registered at clinicaltrials.gov as ISRCTN27657880.
INTRODUCTION
Strong epidemiologic evidence indicated that high consumption of whole-grain foods (WGFs) is associated with low risk of chronic disease such as coronary artery disease (1, 2) , hypertension (3) and type 2 diabetes (4-6). Intervention studies, mostly carried out in animal models, with different types of WGFs or by using supplements of particular components of fibers suggest that dietary whole grain may protect against chronic diseases by altering serum lipid profiles (7) , exerting antioxidant and antithrombotic action (8, 9) and through beneficial effects on vascular reactivity and insulin sensitivity (10) . Furthermore, the differences in composition between types of WGFs seem to determine different lipid responses. In the United Kingdom, WGFs comprise mainly wheat and, to a lesser extent, oats. Oats, and other foods containing high amount of soluble fibers, seem to be effective in reducing plasma total and LDL cholesterol (11, 12) whereas wheat could have triglyceride-lowering effects (7) . A meta-analysis of 12 population-based cohort studies concluded that 3 servings of whole grains/d may be cardioprotective (13) . However, this recommendation has not been properly tested with a large-scale intervention trial. Current UK dietary advice regarding the consumption of WGFs is contained within more general advice to increase the consumption of complex carbohydrates (14) . With low intakes of WGFs being widespread and emerging epidemiologic evidence indicating that increasing the WGF intake to 3 servings/d may be protective against cardiovascular disease (CVD), there was a need to conduct a comprehensive, well-controlled, large-scale human intervention study to support the health claims and to provide a sound scientific basis to justify nutritional policies that advocate an increase in wholegrain intake to combat CVD. This study investigated the effects of dietary supplementation with 3 servings WGFs/d, provided as wheat or a mixture of wheat and oats, on markers of CVD risk [serum lipids and inflammatory marker concentrations, blood pressure (BP), and arterial stiffness] in free-living, healthy, middle-aged volunteers. The primary endpoints were serum total cholesterol and LDL-cholesterol concentrations. The secondary endpoints were markers of insulin sensitivity, inflammation, and BP.
SUBJECTS AND METHODS

Participants
Between September 2005 and December 2008, a single-blind,  randomized controlled dietary intervention study was carried out  with men and women aged 40-65 y who had a body mass index  (BMI; in kg/m 2 ) between 18.5 and 35 and were recruited from the surrounding community of Aberdeen, Scotland. The study was approved by the North of Scotland Research Ethics Committee (04/S0801/66). Sedentary or moderately active subjects (,2 aerobic sessions/wk) were included. Individuals were also included if they presented signs of metabolic syndrome or moderate hypercholesterolemia. Individuals with CVD, diabetes, a fasting blood glucose concentration .7.0 mmol/L, asthma, systolic BP (SBP) .160 mm Hg and diastolic BP (DBP) .99 mm Hg, or thyroid conditions were excluded. Subjects with eating disorders, with high habitual intake of WGFs, or who were taking regular medication or supplements known to affect any dependent variable measured were also excluded.
Study design
A total of 233 participants were recruited to a 16-wk randomized, single-blind, controlled, parallel-designed trial that involved 3 treatment groups (refined, wheat, and oat + wheat diets). After a 4-wk run-in period on a refined diet, volunteers were randomly assigned (stratified by sex, age, and BMI) to the treatment groups. Compliance was determined by dietary assessment on 3 occasions during the intervention. The dietary interventions were designed to be practical and realistic for free-living individuals to achieve, with no alteration of their usual lifestyle. The prescribed dietary changes aimed to compare a diet on the basis of refined cereal products (refined cereals and white bread) with a diet where 3 servings of refined cereals foods were substituted with either 3 servings of whole-wheat foods (70-80 g whole-meal bread + 30-40 g whole-grain cereals) or with 1 serving of whole wheat foods and 2 servings of oats. Participants were provided with refined or wheat-or oat-based WGFs widely available from the main UK food retailers. Aside from the whole-grain servings supplied to the participant, the volunteers selected their own foods to eat; advice on which foods to replace with the supplied wholegrain servings was standardized to each person's regular diet. Servings approached the dietary reference value for nonstarch polysaccharides (NSPs) of 18 g/d (15) . All measurements were performed 4 times (before the run-in period, at baseline, during the intervention, and at completion). Participant's weight, health status, level of exercise, and medication use were also monitored.
Dietary assessment
Dietary intake was assessed by using 7-d food diaries before and during the run-in period as well as during the intervention. Diaries were analyzed with WISP software (version 3.0; Tinuviel Software, Llanfechell, United Kingdom).
BP and anthropometric measurements
BP was measured with an OMRON705CP sphygmomanometer (Omron; Stevenage, Hertfordshire, United Kingdom) according to the guidelines from the British Hypertension Society, with additional consecutive measurements (6 measurements on average), until the last 3 measurements varied by,8%. Arterial stiffness was assessed by pulse contour analysis (Pulse Trace PCA; Micromedical Ltd, Basingstoke, United Kingdom). Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest.
Biochemistry
During each visit, 12-h fasted blood samples were taken from the antecubital fossa vein. Plasma and serum were prepared and stored at 280 C until analysis. All routine lipid analyses were conducted at the Department of Clinical Biochemistry., Aberdeen Royal Infirmary, Aberdeen, United Kingdom, by using the following standardized automated procedures: concentrations of total and HDL cholesterol and triglycerides were measured with automated systems (Siemens, Deerfield, IL), LDL cholesterol was calculated (using the Friedwald equation), and apolipoproteins B 100 and A 1 were analyzed with a nephelometry system (Siemens). All samples were analyzed in a single batch to reduce variability.
Statistical analyses
Statistical analyses were performed with SPSS software (version 17.0; SPSS Inc, Chicago, IL). For descriptive data, results are presented as means 6 SEMs. P values were based on one-factor analysis of variance of differences from baseline. P , 0.05 was the level of significance in the 2-tailed testing. The sample size was based on the primary outcomes of total cholesterol and LDL-cholesterol concentrations. As the variability of cholesterol concentrations between individuals was shown by other authors (16, 17) to be '10-20%, we assumed that the baseline adjustment should reduce the variability to 5-10%, which indicated that 60 subjects per group would give a sufficient experimental power (90%) to detect intervention effects of 5-7%. To allow a dropout of 20% over the trial period, we aimed to recruit 230 participants. At baseline, characteristics of participants in the 3 groups were compared by using one-factor analysis of variance. P values for individual comparisons between diets were adjusted by the Bonferroni method.
RESULTS
Recruitment
A total of 233 volunteers were recruited. Of these volunteers, 24 volunteers withdrew (9 volunteers withdrew for personal reasons, 3 volunteers withdrew for clinical reasons, 2 volunteers were unhappy with the group to which they were randomly assigned, 6 volunteers had digestive problems, 1 volunteer could not adhere to the protocol because of a desire to lose weight, and 3 volunteers were lost to follow-up). Three volunteers did not meet the inclusion criteria and were excluded from analysis. Therefore, 206 participants completed the intervention ( Figure 1 ). However, some food diaries were not returned, which accounted for the lower number of subjects indicated in the tables regarding dietary intakes.
Baseline characteristics
After the run-in period diet, baseline characteristics of the participants (Table 1) were similar between the groups apart from SBP and DBP, which were significantly lower in the wheat group than in the refined and wheat + oats groups. Baseline energy and macronutrient intakes were similar for all groups ( Table 2) , and NSP daily intake, although significantly lower in the refined group than in the whole-grain groups, reflected the average daily NSP intake in Scotland (18) .
Effect of intervention on dietary intake
With the exception of NSPs, macronutrient intakes did not change throughout the trial (data not shown). The interventions with whole grain brought NSP intakes close to the dietary reference value of 18 g/ d (16.8 and 18.5 g/d for wheat + oats and wheat groups, respectively). Intakes were markedly less in the refined group (11.3 g/d; P , 0.001) ( Table 2) . Observed differences in micronutrient intakes ( Table 3 ) reflected compositional differences of the WGFs used and manufacturers' fortification of refined cereals and white flour. Compared with the intakes of the refined group, intakes of zinc and magnesium were significantly greater in both WGF groups, but vitamin B-6 and vitamin D daily intakes were significantly lower. Riboflavin daily intake was significantly lower in the wheat + oats group than in the refined group. Folate intake was significantly higher in the refined group than in the wheat + oats group.
BP
After 6 wk of the intervention, the decrease in SBP in the wheat + oats group (5 mm Hg) was significantly greater than the decrease in the refined group (1.3 mm Hg). By 12 wk, the decrease in SBP in both WGF groups was significantly greater than the decrease in the refined group (P = 0.01; Figure 2A ). However, DBP remained unchanged after intervention ( Figure  2B ). Pulse pressure (PP) was also significantly lower in both WGF groups than in the refined group (Figure 3) , which was an effect that was already apparent in the wheat + oats group (P = 0.03) at 6 wk. The observed decrease in SBP and PP was not related to changes in heart rates or weight loss. We observed no association between the magnitude of the effect and baseline values for BP and BMI. The effect on BP was not correlated with intakes of any of the dietary components (data not shown).
Plasma lipids
Triglyceride concentrations were significantly higher at baseline in the refined group than in the wheat + oats group (Table 4) . However, none of the treatments significantly affected triglyceride, HDL, and apolipoprotein A 1 concentrations. 2 Differences between groups were assessed by using one-factor ANOVA (P , 0.05).
3 Mean 6 SEM (all such values). 4 Calculated by using pulse contour analysis.
Unexpectedly, over the duration of the trial, total cholesterol and LDL-cholesterol concentrations of participants on the refined diet decreased significantly by 3.1% and 4.3%, respectively (Table 4) . These effects were not associated with changes in body weight or macro-and micronutrient dietary components. 2 Differences between groups at baseline were assessed by using one-factor ANOVA, P , 0.05. 3 Differences in intake change from baseline between the dietary intervention groups were assessed by using onefactor ANOVA, P , 0.05. 4 Baseline values with different superscript letters differ significantly (Bonferroni post hoc test). 5 Values with different superscript letters indicate that changes from baseline differ significantly (Bonferroni post hoc test).
TABLE 3
Mean daily micronutrient intake during the 12-wk intervention 
Inflammatory markers and insulin sensitivity
None of the treatments significantly affected high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) ( Table 5) . There were no changes in glucose and insulin concentrations or markers of insulin resistance (homeostatic model assessment of insulin resistance) and sensitivity (revised Quantitative Insulinsensitivity Check Index) ( Table 5) .
DISCUSSION
We showed, for the first time to our knowledge, that daily consumption of 3 portions of WGFs significantly decreased SBP and PP in middle-aged, healthy, overweight men and women. The observed decrease (5-6 mm Hg) was similar to the median reduction in 27 pharmalogic trials (19) and could result in decreases of the incidence of coronary artery disease and stroke by !15% and 25%, respectively (19) . Two meta-analyses concluded that an increase in fiber intake of 10-15 g fiber/d for 8 wk was associated with a fall in SBP of between 1 and 3 mm Hg (3, 20) , and soluble fiber may be more effective than insoluble fiber (20) . However, in our study, both WGF treatments had similar BPlowering effects. To date, dietary intervention trials that described significant decreases in BP have used supplemental (21, 22) or specifically formulated foods (23) in overweight, obese, and hypertensive subjects. In contrast, our study used wholegrain products widely available from UK food retailers and was designed to be readily achievable by free-living individuals.
It was unfortunate that BP in the baseline measurements was significantly different between the groups. However, the significant decreases in BP that resulted from the interventions were not artifactual because they were not in a direction that could be explained by regression to the mean.
The observed decrease in SBP was not related to changes in heart rates or weight loss or to changes in macro-and micronutrients in the diets. Several vitamins (B vitamins and vitamin D) were increased in the refined diet as the result of enrichment of the refined-grain products. However such fortification of the refined-grain values did not appear to have any cardiovascular benefits. The beneficial whole-grain product contained similar concentrations of the vitamins compared with the fortified product. This may indicate that the potential bioactivity of the micronutrients is more marked when part of the natural grain product is present compared with the fortified food.
The reduction in BP observed with the WGF treatments seemed to be also independent of the variation in daily sodium or potassium intake. However, accurate biochemical measurements of sodium and potassium intakes would be required for this to be confirmed.
The cardioprotective effect of WGFs has been at least partly ascribed to their hypocholesterolaemic properties, particularly for whole grain such as oats and barley that contain relatively high amount of viscous soluble fiber (24) . The many intervention studies using b-glucan-enriched foods or supplements (25) (26) (27) (28) have had variable outcomes, but 3 g b-glucan/d (equivalent to '60 g oatmeal) appears to be the minimum amount required to achieve a clinically relevant decrease in serum cholesterol. The lack of a beneficial effect of the WGF interventions on blood lipid concentrations may be because we did not include severely hypercholesterolemic volunteers. Surprisingly, total cholesterol and LDL-cholesterol concentrations were slightly but significantly decreased in the refined group after 12 wk of intervention. This was not associated with changes in body weight or any dietary factors known to affect cholesterol concentrations.
Epidemiologic studies have reported a positive relation between whole-grain intake and insulin sensitivity (29) . Small 2 Differences at baseline were assessed by using one-factor ANOVA, P , 0.05. For insulin, hsCRP, and IL-6, onefactor ANOVA was performed on log-transformed values.
3 Differences in concentration changes from baseline between the dietary intervention groups were assessed by using one-factor ANOVA, P , 0.05. None of the differences were significant. 4 Median; interquartile range in parentheses (all such values). intervention trials with supplemental fiber (30, 31) None of the interventions significantly affected systemic markers of inflammation (ie, hsCRP and IL-6). Our results agree with previous findings (34) that showed nonsignificant associations between whole-grain intake and concentrations of IL-6.
Most of the findings from the current study confirm the results recently published from another comprehensive 16-wk intervention trial (the WHOLEheart study) with whole grains that involved 316 overweight adults (35) . The authors observed no beneficial effects on blood lipids, insulin sensitivity, and inflammatory and coagulation status. However, BP was also unaffected. As suggested recently (36), these findings do not necessarily question the efficacy of increasing WGF intake in relation to CVD risk but highlight some of the limitations inherent to randomized controlled trials when looking at foods or nutrients. The authors (35) indicated that WGFs would fit within the concept of a phytochemical-rich dietary pattern that could be useful to base dietary recommendations for the public. However, our randomized controlled trial showed a direct effect of WGF consumption on BP. In the WHOLEheart trial, BP results were averaged from only 2 consecutive measurements. Such a methodology might be useful to identify hypertensive subjects but does not represent a precise method for measuring BP. Furthermore, participants involved in the WHOLEheart study included WGFs as additions to their regular diet, whereas volunteers from the current study substituted refined items with whole grains.
Although the mechanisms by which WGFs decrease BP remain unclear, our findings have important public health implications and provide a sound scientific basis for advising the daily consumption of 3 servings of WGF to combat CVD. In addition, dietary intervention with whole grains along with pharmacologic treatment of hypertension may have significant cost benefits to the National Health Service in the United Kingdom and decrease drug-related side effects.
